[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100516329":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":34,"locations":39,"responsibleParty":55,"collaborators":25,"id":58,"slug":59,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":64,"eligibilityCriteria":65,"healthyVolunteers":60,"sex":66,"minAge":67,"maxAge":25,"enrollmentInfo":68,"targetDuration":25,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":80,"overallStatus":41,"whyStopped":25,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"Massachusetts General Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Bone marrow aspirate concentrate (BMAC)","EXPERIMENTAL","Patients randomly allocated to receive BMAC will undergo hip arthroscopy and will receive PRP\u002FPPP\u002FBMAC application through the PI's standardized method of harvest, processing, and application.",[13],"Biological: Bone marrow aspirate concentrate (BMAC)",{"label":15,"type":16,"description":17,"interventionNames":18},"Control","PLACEBO_COMPARATOR","Patients allocated to the control cohort will receive standard of care hip arthroscopy without PRP\u002FPPP\u002FBMAC application.",[19],"Procedure: Control",[21,26],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"BIOLOGICAL","Bone marrow aspiration from the body of the ilium will be performed through one of the arthroscopic portals.",[9],null,{"type":27,"name":15,"description":28,"armGroupLabels":29,"otherNames":25},"PROCEDURE","Standard of care hip arthroscopy without bone marrow aspiration will be performed in these patients.",[15],[31],{"name":32,"affiliation":5,"role":33},"Scott D. Martin, MD","PRINCIPAL_INVESTIGATOR",[35],{"name":32,"role":36,"phone":37,"phoneExt":25,"email":38},"CONTACT","617-732-5329","sdmartin@mgh.harvard.edu",[40],{"facility":5,"status":41,"city":42,"state":43,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"RECRUITING","Boston","Massachusetts","02114","United States","US",{"type":48,"coordinates":49},"Point",[50,51],-71.05977,42.35843,{"lat":51,"lon":50},[54],{"name":32,"role":36,"phone":25,"phoneExt":25,"email":25},{"type":33,"investigatorFullName":56,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"Scott D Martin","Principal Investigator; Director, Joint Preservation Service; Director, MGH Sports Medicine Fellowship","100516329","phase-3-effect-of-prp-ppp--bmac-on-functional-outcomes-following-hip-arthroscopy-for-acetabular-labral-pathologies-100516329",false,"NCT06003101","Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies","Effect of Platelet-Rich Plasma, Platelet-Poor Plasma, & Bone Marrow Aspirate Concentrate Application on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies: A Prospective Randomized Controlled Trial","PRP; PPP; BMAC","Inclusion Criteria:\n\n* Age: \\> or equal to 18 years\n* Clinically indicated for hip arthroscopy (by the study PI) to address a labral pathology\n* Willingness to participate, amenable to randomization into either treatment arm of the research study, and the ability to understand \\& sign the informed consent document\n\nExclusion Criteria:\n\n* Non-English speaking (PROM surveys are only validated in English)\n* Prior same site (i.e., ipsilateral hip) surgery, including but not limited to previous hip arthroscopy, core decompression, or periacetabular osteotomies","ALL","18 Years",{"count":69,"type":70},160,"ESTIMATED","INTERVENTIONAL",[73],"PHASE3","The goal of this clinical trial is to assess the effect of PRP\u002FPPP\u002FBMAC application on functional outcomes after hip arthroscopy to address acetabular labral pathologies. The main questions it aims to answer are:\n\n1. Does PRP\u002FPPP\u002FBMAC application improve functional outcomes after hip arthroscopy to address acetabular labral pathologies?\n2. Does PRP\u002FPPP\u002FBMAC application reduce the arthritic burden as measured by functional outcomes following hip arthroscopy to address labral pathologies with concomitant PRP\u002FPPP\u002FBMAC application?",[76,77,78,79],"Acetabular Labrum Tear","Femoro Acetabular Impingement","Chondral Defect","Bone Marrow Aspirate Concentrate",[76,77,78,79,81,82,83,84],"Chondrolabral Junction","Osteoarthritis","Hip Arthroscopy","BMAC","2024-11-18",{"date":87,"type":88},"2024-11-20","ACTUAL",{"date":90,"type":88},"2023-08-30",{"date":92,"type":70},"2045-08-30",{"name":5,"class":6},1]